'For quarter ended Dec 2023, consolidated Net sales (including other operating income) of Syngene International has increased 8.60% to Rs 853.5 crore compared to quarter ended Dec 2022.  Operating profit margin has declined from 29.39% to 27.12%, leading to 0.22% rise in operating profit to Rs 231.50 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 27.29% to 28.06%.   Employee cost decreased from 26.44% to 25.79%.   Other expenses rose from 17.30% to 19.11%.   

Other income rose 70.35% to Rs 29.3 crore.  PBIDT rose 5.08% to Rs 260.8 crore.  Provision for interest fell 21.17% to Rs 10.8 crore.  

PBDT rose 6.61% to Rs 250 crore.  Provision for depreciation rose 14.27% to Rs 108.1 crore.  

Profit before tax grew 1.43% to Rs 141.90 crore.  Share of profit/loss were nil in both the periods.  Provision for t...

• 

  (28-Feb-2026)

  Vesuvius India

  Net jumps 33% on higher OI
• 

  (26-Feb-2026)

  Foseco India

  Net down 35% on higher EO Exp
• 

  (26-Feb-2026)

  KSB

  Net up 11%, sales up 8%
• 

  (26-Feb-2026)

  Sanofi India

  OP down 23.67%